BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16442944)

  • 1. Predictors of cancer in patients with suspected pancreatic malignancy without a tissue diagnosis.
    Tessler DA; Catanzaro A; Velanovich V; Havstad S; Goel S
    Am J Surg; 2006 Feb; 191(2):191-7. PubMed ID: 16442944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer.
    Kang CM; Kim JY; Choi GH; Kim KS; Choi JS; Lee WJ; Kim BR
    J Surg Res; 2007 Jun; 140(1):31-5. PubMed ID: 17418869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative carbohydrate antigen 19-9 is most predictive of malignancy in older jaundiced patients undergoing pancreatic resection.
    Bloomston M; Bekaii-Saab TS; Kosuri K; Cowgill SM; Melvin WS; Ellison EC; Muscarella P
    Pancreas; 2006 Oct; 33(3):246-9. PubMed ID: 17003645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is the carbohydrate antigen Ca 19.9 useful in the diagnosis of pancreatic carcinoma?].
    Santander C; Jiménez I; Martín E; Melón A; Pajares JM
    Rev Esp Enferm Dig; 1994 Nov; 86(5):819-21. PubMed ID: 7848693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How useful are clinical, biochemical, and cross-sectional imaging features in predicting potentially malignant or malignant cystic lesions of the pancreas? Results from a single institution experience with 220 surgically treated patients.
    Goh BK; Tan YM; Thng CH; Cheow PC; Chung YF; Chow PK; Wong WK; Ooi LL
    J Am Coll Surg; 2008 Jan; 206(1):17-27. PubMed ID: 18155564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
    Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
    Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer].
    Deng RX; Lu XH; Wang L; Li H; Qian JM; Yang AM; Zhong SX; Guo XZ; Zhou L; Wu X; Yang XO; Jiang WJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2038-42. PubMed ID: 16313796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of solid pancreatic masses by endoscopic ultrasound-guided fine-needle aspiration.
    Wilson JL; Kalade A; Prasad S; Cade R; Thomson B; Banting S; Mackay S; Desmond PV; Chen RY
    Intern Med J; 2009 Jan; 39(1):32-7. PubMed ID: 18422561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
    Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
    Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S
    J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
    Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
    JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia.
    Shami VM; Sundaram V; Stelow EB; Conaway M; Moskaluk CA; White GE; Adams RB; Yeaton P; Kahaleh M
    Pancreas; 2007 May; 34(4):466-9. PubMed ID: 17446847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological features in misdiagnosed pancreatic carcinoma.
    Nagahama H; Okada S; Okusaka T; Ishii H; Ikeda M; Nakasuka H; Yoshimori M
    Hepatogastroenterology; 1999; 46(29):2983-5. PubMed ID: 10576387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
    Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
    J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic and bile duct brushing cytology in 1000 cases: review of findings and comparison of preparation methods.
    Volmar KE; Vollmer RT; Routbort MJ; Creager AJ
    Cancer; 2006 Aug; 108(4):231-8. PubMed ID: 16541448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of the proteolysis-inducing factor in urine does not predict the malignancy of a pancreatic tumour.
    Teich N; Kleeff J; Lochs H; Mössner J; Keim V; Friess H; Ockenga J
    BMC Gastroenterol; 2005 Jun; 5():20. PubMed ID: 15969757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosonography- vs. endoscopic retrograde cholangiopancreatography-based strategies in the evaluation of suspected common bile duct stones in patients with normal transabdominal imaging.
    Ang TL; Teo EK; Fock KM
    Aliment Pharmacol Ther; 2007 Oct; 26(8):1163-70. PubMed ID: 17894658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients.
    Pelaez-Luna M; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1759-64. PubMed ID: 17686073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Does cholestasis change the clinical usefulness of CA 19-9 in pacreatobiliary cancer?].
    Mery CM; Duarte-Rojo A; Paz-Pineda F; Gómez E; Robles-Díaz G
    Rev Invest Clin; 2001; 53(6):511-7. PubMed ID: 11921523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics.
    Krishna NB; Mehra M; Reddy AV; Agarwal B
    Gastrointest Endosc; 2009 Jul; 70(1):70-9. PubMed ID: 19249774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.